iShares Neuroscience and Healthcare ETF (IBRN)

Assets	$5.00M
Expense Ratio	0.47%
PE Ratio	16.48
Shares Out	150,000
Dividend (ttm)	$0.32
Dividend Yield	0.98%
Ex-Dividend Date	Dec 16, 2025
Payout Frequency	Annual
Payout Ratio	15.88%

Volume	1,478
Open	32.57
Previous Close	33.02
Day's Range	32.57 - 32.61
52-Week Low	17.86
52-Week High	37.00
Beta	0.72
Holdings	69
Inception Date	Aug 24, 2022

About IBRN

Fund Home Page

The iShares Neuroscience and Healthcare ETF (IBRN) is an exchange-traded fund that mostly invests in health care equity. The fund tracks a market cap-weighted index that provides global equity exposure to companies that are positioned to benefit from neuroscience advancements. The index may hold securities from large- to small-cap. IBRN was launched on Aug 24, 2022 and is issued by BlackRock.

• Asset Class: Equity
• Category: Health
• Region: Global
• Stock Exchange: NYSEARCA
• Ticker Symbol: IBRN
• ETF Provider: BlackRock
• Index Tracked: NYSE FactSet Global Neuro Biopharma and MedTech Index

Top 10 Holdings

40.68% of assets

Name	Symbol	Weight
Praxis Precision Medicines, Inc.	PRAX	4.97%
Axsome Therapeutics, Inc.	AXSM	4.86%
Alkermes plc	ALKS	4.63%
Scholar Rock Holding Corporation	SRRK	3.91%
PTC Therapeutics, Inc.	PTCT	3.88%
Biogen Inc.	BIIB	3.81%
argenx SE	ARGX	3.68%
ACADIA Pharmaceuticals Inc.	ACAD	3.67%
Denali Therapeutics Inc.	DNLI	3.64%
Xenon Pharmaceuticals Inc.	XENE	3.64%

Dividend History

Ex-Dividend	Amount	Pay Date
Dec 16, 2025	$0.31981	Dec 19, 2025
Dec 17, 2024	$0.10114	Dec 20, 2024
Dec 20, 2023	$0.0063	Dec 27, 2023
Jun 7, 2023	$0.00824	Jun 13, 2023

Performance

IBRN had a total return of 26.44% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.14%.